Evidence map›Paper›PMID 25552542›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2015

Apoptosis-associated speck-like protein containing a CARD forms specks but does not activate caspase-1 in the absence of NLRP3 during macrophage swelling.

Vincent Compan, Fátima Martín-Sánchez, Alberto Baroja-Mazo, Gloria López-Castejón, Ana I Gomez, Alexei Verkhratsky, David Brough, Pablo Pelegrín

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 60 papers.

0numbers the graph read from it
0cells of the map it votes in
60citing papers in PubMed
3.9field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

60 citing papers in PubMed, 108 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. ASC-expressing pyroptotic extracellular vesicles alleviate sepsis by protecting B cells.Molecular therapy : the journal of the American Society of Gene Therapy · 2024
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Vincent CompanFaculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom; and.
Fátima Martín-SánchezUnidad de Inflamación y Cirugía Experimental, Centro de Investigación Biomédica en Red en el Área Temática de Enfermedades Hepáticas y Digestivas, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain pablo.pelegrin@ffis.es fatima.martin@ffis.es.
Alberto Baroja-MazoUnidad de Inflamación y Cirugía Experimental, Centro de Investigación Biomédica en Red en el Área Temática de Enfermedades Hepáticas y Digestivas, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain.
Gloria López-CastejónFaculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom; and.
Ana I GomezUnidad de Inflamación y Cirugía Experimental, Centro de Investigación Biomédica en Red en el Área Temática de Enfermedades Hepáticas y Digestivas, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain.
Alexei VerkhratskyFaculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom; and.
David BroughFaculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom; and.
Pablo PelegrínFaculty of Life Sciences, University of Manchester, Manchester M13 9PT, United Kingdom; and Unidad de Inflamación y Cirugía Experimental, Centro de Investigación Biomédica en Red en el Área Temática de Enfermedades Hepáticas y Digestivas, Hospital Clínico Universitario Virgen de la Arrixaca, Instituto Murciano de Investigación Biosanitaria-Arrixaca, 30120 Murcia, Spain pablo.pelegrin@ffis.es fatima.martin@ffis.es.ORCID http://orcid.org/0000-0002-9688-1804
University of Manchester · GBCentro de Investigación Biomédica en Red · ES

Funding

European Research Council 614578Wellcome Trust
6 · The paper itself

Abstract

Apoptosis-associated speck-like protein containing a C-terminal caspase recruitment domain (ASC) is a key adaptor molecule required for the inflammatory processes. ASC acts by bridging NLRP proteins, such as NLRP3, with procaspase-1 within the inflammasome complex, which subsequently results in the activation of caspase-1 and the secretion of IL-1β and IL-18. In response to bacterial infection, ASC also forms specks by self-oligomerization to activate caspase-1 and induce pyroptosis. Hitherto, the role of these specks in NLRP3 inflammasome activation in response to danger signals, such as a hypotonic environment, largely has been unexplored. In this article, we report that, under hypotonic conditions and independently of NLRP3, ASC was able to form specks that did not activate caspase-1. These specks were not associated with pyroptosis and were controlled by transient receptor potential vanilloid 2 channel-mediated signaling. However, interaction with NLRP3 enhanced ASC speck formation, leading to fully functional inflammasomes and caspase-1 activation. This study reveals that the ASC speck can present different oligomerization assemblies and represents an essential step in the activation of functional NLRP3 inflammasomes.

Indexed as

AnimalsApoptosis Regulatory ProteinsCalcium ChannelsCARD Signaling Adaptor ProteinsCarrier ProteinsCaspase 1Cell LineEnzyme ActivationHumansInflammasomesMacrophagesMaleMiceMice, KnockoutNLR Family, Pyrin Domain-Containing 3 ProteinProtein Interaction Domains and MotifsApoptosis Regulatory ProteinsCalcium ChannelsCARD Signaling Adaptor ProteinsCarrier ProteinsCaspase 1InflammasomesNLR Family, Pyrin Domain-Containing 3 ProteinNlrp3 protein, mousePycard protein, mouseTrpv2 protein, mouseTRPV Cation Channels

Identifiers

PMID25552542
PMCPMC4883655
OpenAlexW2116083544

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.